Tenofovir fumarate dipivoxil (tablets) is a nucleotide reverse transcriptase inhibitor, which is mainly used in the treatment of AIDS, hepatitis B and other diseases
BASF headquarters has confirmed novel coronavirus pneumonia and its close contacts have been quarantined at home
Time of Update: 2020-03-25
If employees return from these areas for business or personal reasons, they must be isolated at home for 14 days.
Big things happen! Wanhua chemical and Fujian Petrochemical work together to further monopolize the new MDI capacity and TDI market in China
Time of Update: 2020-03-04
On March 4, Wanhua chemical issued a foreign investment announcement that Wanhua Chemical Group Co., Ltd
and Fujian Petrochemical Group Co., Ltd
A large number of pharmaceutical enterprises will usher in a period of concentrated harvest in the transformation from pharmaceutical enterprises to innovation
Time of Update: 2020-02-20
With the increase of investment in innovative research and development, a large number of pharmaceutical enterprises have recently indicated that innovative drugs will enter the period of centralized harvest.
Novel coronavirus pneumonia is a potential effective drug, and the sea is being approved by the public
Time of Update: 2020-02-17
Zhejiang Haizheng issued a notice that it received the approval of drug registration and approval of clinical trial of faveravir tablets (also known as fapiravir tablets) approved
AI pharmaceutical trend is obvious! What are the possibilities besides improving R & D Efficiency
Time of Update: 2020-02-06
In fact, new drug research and development cycle is long, investment is large, lasting for a long time, and efficiency is low, which has always been a "serious problem" in the field of medicine.
The era of innovative medicine is coming at an accelerated speed, with three major development trends at present
Time of Update: 2019-12-23
With the continuous breakthrough of biomedical industry technology and the increasing investment in research and development of pharmaceutical enterprises, according to iqvia, China's biomedical market may become the global pharmaceutical market next to the United States by 2020.
In November, 30 pharmaceutical companies were involved in the be test publicity of consistency evaluation
Time of Update: 2019-12-17
Data source of this report: insight database, CDE drug clinical trial registration and information publicity data statistics as of December 11, clinical trial publicity November 2019, in CDE There are 232 published clinical trials.
How is the overall performance of the pharmaceutical sector in the near future? Obvious advantages of biopharmaceuticals
Time of Update: 2019-11-25
According to the results of the first three quarters of this year's Chinese patent medicine industry, 44 out of 69 listed companies exceeded their expectations, accounting for 63.77%.
How about the pharmaceutical intermediates Market in 2019? Many enterprises have increased their orders
Time of Update: 2019-11-21
[pharmaceutical network market analysis] pharmaceutical intermediates refer to intermediate chemicals made in the process of chemical drug synthesis
Warmly congratulate Ningbo Haoxin Yulong New Material Co., Ltd. on winning the title of "green factory in petroleum and chemical industry
Time of Update: 2019-11-21
November 11-13, 2019 green development conference of petroleum and chemical industry and new technologies, products and equipment exchange meeting of clean production and environmental protection were held in East China Hotel, Nanjing.
Erkang Pharmaceutical (300267. SZ) plans to increase the production of Chinese herbal extracts in its business scope
Time of Update: 2019-11-19
On November 14, gronhui Pharmaceutical (300267
SZ) announced that the company held the first meeting of the Fourth Board of directors on November 14, 2019, deliberated
Chongqing Heavy Pharmaceutical Co., Ltd. plans to acquire 3.35% shares of Chongqing pharmaceutical Co., Ltd. with RMB 337 million
Time of Update: 2019-11-14
On November 13, Chongqing Pharmaceutical Group Co., Ltd
issued a notice on the acquisition of minority shareholders' equity of Chongqing pharmaceutical (Group) Co., Ltd
Good policies have been issued continuously, and the traditional Chinese medicine sector still has investment value
Time of Update: 2019-10-29
The industry believes that in the long run, the pharmaceutical companies will benefit from the new products or products with large market share entering the medical insurance catalog.
[one week countdown to registration] pharmacon 2019's guests' big exposure - a boutique R & D forum that chemical companies can't miss
Time of Update: 2019-09-06
Pharmacon 2019, the Fifth China International Chemical Research and development forum, will be held on September 24-25 in Regal global East Asia Hotel, Shanghai.
Announcement on the cancellation of pledge of equity of the controlling shareholder of weighing pharmaceutical
Time of Update: 2019-06-26
The share of the released pledge shares accounted for 16.52% of the total shares of the company held by chemical medical group and 6.36% of the total equity of Sinopharm holdings.
Erkang's net profit dropped 56.65% year on year, mainly due to these three points
Time of Update: 2019-02-28
On February 27, Erkang Pharmaceutical (300267) released the performance express report
From January to December 2018, the company achieved an operating revenue of 2.380
Good news! Zhongsheng pharmaceutical special subject is listed in the national major science and technology special project of "major new drug creation
Time of Update: 2019-01-07
Recently, Zhongsheng pharmaceutical released a notice that its company recently received the notice on the second batch of projects for the implementation plan of major science